Pharmaceutical Benefits Advisory Committee recommends mifepristone (RU486) be listed on the PBS
The Pharmaceutical Benefits Advisory Committee has recommended that mifepristone (RU486)
April 27, 2013
The Pharmaceutical Benefits Advisory Committee has recommended that mifepristone (RU486)
Like to receive AFMW news direct to your email? Please enter your details below to join our list. Please note subscribing to our mailing list does not confer AFMW membership.